Vedanta Biosciences
A biotechnology company that develops medicines based on live bacterial consortia that can colonize the human intestine.
13
Funding Rounds
$386.6m
Money raised
Overview
A biotechnology company that develops medicines based on live bacterial consortia that can colonize the human intestine.
-
Website:
- Business model: B2B B2C
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Al** Ru* | - | - | - |
| Da* R. Li | - | - | - |
| KE*** HO*** | - | - | - |
| RU**** ME** | - | - | - |
| Be**** Ol** |
|
- | |
| Br*** Fi**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Vedanta Biosciences has raised a total of $305.8m in funding over 13 rounds.
Key Insights:
- Vedanta Biosciences Series D round, July 2021: $68m
- Vedanta Biosciences Venture round, January 12, 2021: $25m
- Vedanta Biosciences Grant (money), September 30, 2020: $76.9m
- Vedanta Biosciences funding round, September 2019: $16.6m
- Vedanta Biosciences Series C round, May 13, 2019: $18.5m
- Vedanta Biosciences Series C round, December 24, 2018: $45.4m
- Vedanta Biosciences Grant (money), November 3, 2017: $5.4m
- Vedanta Biosciences Private equity, June 6, 2016: $50m
- Vedanta Biosciences Grant (money), December 2019: $5.8m
- VEDANTA BIOSCIENCES, INC. funding round, August 2021: $75m
Vedanta Biosciences Series D round, July 2021
$68m
Vedanta Biosciences Venture round, January 12, 2021
$25m
Vedanta Biosciences Grant (money), September 30, 2020
$76.9m
Vedanta Biosciences funding round, September 2019
$16.6m
Vedanta Biosciences Series C round, May 13, 2019
$18.5m
Vedanta Biosciences Series C round, December 24, 2018
$45.4m
Vedanta Biosciences Grant (money), November 3, 2017
$5.4m
Vedanta Biosciences Private equity, June 6, 2016
$50m
Vedanta Biosciences Grant (money), December 2019
$5.8m
VEDANTA BIOSCIENCES, INC. funding round, August 2021
$75m
Industries
Vedanta Biosciences is active in the following industries: